• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非周末阅读时间表用于结核分枝杆菌放射测量法吡嗪酰胺药敏试验的多中心评估

Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

作者信息

Madison B, Gross W, George I, Sloutsky A, Washabaugh G, Robinson-Dunn B, Lipman H, Metchock B, Mazurek G, Ridderhof J

机构信息

Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mail Stop G-25, Atlanta, GA 30347, USA.

出版信息

J Clin Microbiol. 2002 Oct;40(10):3753-6. doi: 10.1128/JCM.40.10.3753-3756.2002.

DOI:10.1128/JCM.40.10.3753-3756.2002
PMID:12354876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC130879/
Abstract

Pyrazinamide (PZA) is an integral component of the short-course chemotherapy regimen for tuberculosis. The BACTEC 460TB PZA susceptibility test for Mycobacterium tuberculosis with a daily (D) reading schedule has been available for more than 10 years, but weekend laboratory staffing is necessary. A nonweekend (NW) reading schedule has not been validated in a multicenter study. This prospective multicenter study compares the interlaboratory reproducibility of PZA susceptibility results by following both the D and NW schedules. A total of 181 cultures were shared among four laboratories. Isolates were selected based on resistance or borderline resistance to at least one streptomycin-isoniazid-rifampin-ethambutol drug or PZA. One laboratory used a D reading schedule, and three laboratories used a NW schedule. Both reading schedules are based on the standard BACTEC 460TB PZA protocol. With the NW schedule, the growth index (GI) is not available for test interpretation on Saturday, Sunday, and Monday. Of the 181 shared cultures, 154 were found to be susceptible by all laboratories, 19 were found to be resistant, and 8 had discordant results. The overall pairwise interlaboratory agreement was 97.7%. The discrepancies were not associated with the type of reading schedule used. However, the median control GI was significantly higher for the NW schedule (321) than for the D schedule (259) (P < 0.0001) although results were available on average in about 7 days from setup for both schedules. These results show that the NW schedule is a suitable alternative for laboratories that do not read and interpret PZA susceptibility tests on weekends.

摘要

吡嗪酰胺(PZA)是结核病短程化疗方案的一个重要组成部分。用于结核分枝杆菌的BACTEC 460TB PZA药敏试验,每日(D)读数方案已应用超过10年,但周末需要实验室工作人员值班。非周末(NW)读数方案尚未在多中心研究中得到验证。这项前瞻性多中心研究通过遵循D和NW方案比较了PZA药敏结果的实验室间重复性。四个实验室共分享了181株培养物。根据对至少一种链霉素-异烟肼-利福平-乙胺丁醇药物或PZA的耐药或临界耐药情况选择分离株。一个实验室采用D读数方案,三个实验室采用NW方案。两种读数方案均基于标准的BACTEC 460TB PZA方案。采用NW方案时,周六、周日和周一无法获得生长指数(GI)用于试验判读。在181株共享培养物中,所有实验室均发现154株敏感,19株耐药,8株结果不一致。实验室间总体两两一致性为97.7%。差异与所采用的读数方案类型无关。然而,NW方案的对照GI中位数(321)显著高于D方案(259)(P<0.0001),尽管两种方案从接种开始平均约7天可获得结果。这些结果表明,对于不在周末进行PZA药敏试验判读的实验室,NW方案是一种合适的替代方案。

相似文献

1
Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.非周末阅读时间表用于结核分枝杆菌放射测量法吡嗪酰胺药敏试验的多中心评估
J Clin Microbiol. 2002 Oct;40(10):3753-6. doi: 10.1128/JCM.40.10.3753-3756.2002.
2
Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.BacT/ALERT PZA试剂盒与BACTEC 460TB PZA用于检测结核分枝杆菌对吡嗪酰胺敏感性的比较评估。
J Antimicrob Chemother. 2007 Sep;60(3):655-7. doi: 10.1093/jac/dkm252. Epub 2007 Jul 5.
3
Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.评估全自动BACTEC MGIT 960系统检测结核分枝杆菌对吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇的药敏性,并与放射性BACTEC 460TB方法进行比较。
J Clin Microbiol. 2004 Mar;42(3):1109-14. doi: 10.1128/JCM.42.3.1109-1114.2004.
4
[Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].[土耳其马尼萨地区对吡嗪酰胺单耐药的结核分枝杆菌]
Mikrobiyol Bul. 2008 Oct;42(4):585-90.
5
Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.使用非放射性BACTEC MGIT 960系统检测结核分枝杆菌对吡嗪酰胺的敏感性。
J Clin Microbiol. 2002 May;40(5):1670-4. doi: 10.1128/JCM.40.5.1670-1674.2002.
6
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.采用琼脂比例法和放射测量法对结核分枝杆菌乙胺丁醇药敏试验进行多中心评估。
J Clin Microbiol. 2002 Nov;40(11):3976-9. doi: 10.1128/JCM.40.11.3976-3979.2002.
7
Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry.利用流式细胞术对结核分枝杆菌进行快速吡嗪酰胺药敏试验。
J Microbiol Methods. 2006 Nov;67(2):266-72. doi: 10.1016/j.mimet.2006.03.020. Epub 2006 May 15.
8
Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
Chest. 2007 Feb;131(2):497-501. doi: 10.1378/chest.06-1899.
9
Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.用于检测结核分枝杆菌对一线药物敏感性的分枝杆菌生长指示管的多中心评估。
J Clin Microbiol. 1999 Jan;37(1):45-8. doi: 10.1128/JCM.37.1.45-48.1999.
10
Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system.全自动Bactec MGIT 960系统用于结核分枝杆菌对吡嗪酰胺药敏试验的多中心评估:与放射性Bactec 460TB系统的比较
J Microbiol Methods. 2003 Oct;55(1):331-3. doi: 10.1016/s0167-7012(03)00142-8.

引用本文的文献

1
Msx1 loss suppresses formation of the ectopic crypts developed in the Apc-deficient small intestinal epithelium.Msx1 缺失抑制了 Apc 缺陷型小肠上皮中异位隐窝的形成。
Sci Rep. 2019 Feb 7;9(1):1629. doi: 10.1038/s41598-018-38310-y.
2
Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.包括阿米卡星在内的成功耐多药结核病治疗方案与高听力损失率相关。
BMC Infect Dis. 2014 Oct 9;14:542. doi: 10.1186/1471-2334-14-542.

本文引用的文献

1
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.可能影响结核分枝杆菌对吡嗪酰胺药敏试验结果的情况。
J Med Microbiol. 2002 Jan;51(1):42-49. doi: 10.1099/0022-1317-51-1-42.
2
Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.结核分枝杆菌吡嗪酰胺药敏试验的表型和基因型方法比较
J Clin Microbiol. 2000 Oct;38(10):3686-8. doi: 10.1128/JCM.38.10.3686-3688.2000.
3
New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.用于检测结核分枝杆菌对吡嗪酰胺敏感性的新型琼脂培养基。
J Clin Microbiol. 2000 Apr;38(4):1498-501. doi: 10.1128/JCM.38.4.1498-1501.2000.
4
Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity.分枝杆菌中吡嗪酰胺耐药机制:除缺乏吡嗪酰胺酶活性外,摄取缺乏的重要性。
Microbiology (Reading). 1999 Jun;145 ( Pt 6):1359-1367. doi: 10.1099/13500872-145-6-1359.
5
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.俄罗斯西北部耐吡嗪酰胺结核分枝杆菌分离株中的pncA基因突变
Antimicrob Agents Chemother. 1999 Jul;43(7):1764-6. doi: 10.1128/AAC.43.7.1764.
6
Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.结核分枝杆菌复合群生物体中与吡嗪酰胺耐药相关的pncA基因突变。
Antimicrob Agents Chemother. 1997 Mar;41(3):636-40. doi: 10.1128/AAC.41.3.636.
7
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.耐吡嗪酰胺结核分枝杆菌中pncA基因突变的特征分析
Antimicrob Agents Chemother. 1997 Mar;41(3):540-3. doi: 10.1128/AAC.41.3.540.
8
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.编码吡嗪酰胺酶/烟酰胺酶的基因pncA发生突变,会导致结核杆菌对抗结核药物吡嗪酰胺产生耐药性。
Nat Med. 1996 Jun;2(6):662-7. doi: 10.1038/nm0696-662.
9
The resurgence of tuberculosis: is your laboratory ready?结核病的卷土重来:你的实验室准备好了吗?
J Clin Microbiol. 1993 Apr;31(4):767-70. doi: 10.1128/jcm.31.4.767-770.1993.
10
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.耐多药时代的结核病初始治疗。消除结核病咨询委员会的建议。
MMWR Recomm Rep. 1993 May 21;42(RR-7):1-8.